Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18916)

• Formulation Name: Repaglinide 2 mg tablet
• Company: Paddock Laboratories,

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Repaglinide	(DM5SXUV)	Diabetic complication	5A2Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium hydrogenphosphate	(E00294)	24441	Diluent
Eisenoxyd	(E00585)	56841934	Colorant
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Magnesium stearate	(E00208)	11177	lubricant
Meglumine	(E00181)	8567	Buffering agent
Poloxamer 407	(E00646)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent